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Abstract
Background: African Americans have persistently poor access to living donor kidney transplants (LDKT). We conducted a
small randomized trial to provide preliminary evidence of the effect of informational decision support and donor financial
assistance interventions on African American hemodialysis patients’ pursuit of LDKT.
Methods: Study participants were randomly assigned to receive (1) Usual Care; (2) the Providing Resources to Enhance
African American Patients’ Readiness to Make Decisions about Kidney Disease (PREPARED); or (3) PREPARED plus a living
kidney donor financial assistance program. Our primary outcome was patients’ actions to pursue LDKT (discussions with
family, friends, or doctor; initiation or completion of the recipient LDKT medical evaluation; or identification of a donor).
We also measured participants’ attitudes, concerns, and perceptions of interventions’ usefulness.
Results: Of 329 screened, 92 patients were eligible and randomized to Usual Care (n = 31), PREPARED (n = 30), or
PREPARED plus financial assistance (n = 31). Most participants reported interventions helped their decision
making about renal replacement treatments (62%). However there were no statistically significant improvements in
LDKT actions among groups over 6 months. Further, no participants utilized the living donor financial assistance benefit.
Conclusions: Findings suggest these interventions may need to be paired with personal support or navigation services
to overcome key communication, logistical, and financial barriers to LDKT.
Trial registration: ClinicalTrials.gov [NCT01439516] [August 31, 2011].
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Background
For over 10 years, there have been growing efforts to
improve patients’ access to living donor kidney transplant-
ation (LDKT). Patient advocacy, professional and govern-
ment organizations have invested substantial resources
[1–5] to support these efforts. Despite this, LDKT rates
have plateaued in recent years, underscoring the urgency
to establish best practices to improve LDKT access [6].
Inadequate access to LDKT has been especially problem-
atic for African Americans who have had persistently
lower rates of LDKT compared to others [7, 8].
African American patients with kidney failure confront
numerous barriers to LDKT including poor awareness
[9] and knowledge [10] of LDKT, difficulty identifying
donors [11–13], as well as financial barriers [14, 15] to
LDKT. Evidence shows African Americans are less likely
than Whites to be fully informed of their treatment
options, including LDKT, before initiating hemodialysis
[9, 10]. African Americans have also been shown to be
highly sensitive to the financial impact of living kidney
donation on potential donors, further limiting their
LDKT utilization [14, 16]. Interventions to increase
African American patients’ knowledge of LDKT have
been widely advocated as important to help address dis-
parities [17, 18]. The National Living Donor Assistance
Program [19] also provides financial assistance to low in-
come LDKT donors to help address disparities. While
these efforts have been in place for some time, their up-
take and effectiveness to improve LDKT rates among
African Americans have not been well studied.
Interventions enabling informed decisions about LDKT
and providing financial support for LDKT could be par-
ticularly useful for African American patients who have
recently initiated dialysis, as they may be poorly educated
about kidney treatments, unaware of potential financial
support, and still in the early phases of making longer-
term decisions about LDKT. However, evidence to
support the widespread adoption of these interventions
does not yet exist. We conducted a small randomized
clinical trial among urban African Americans receiving
hemodialysis to examine the potential effectiveness of de-
livering informational decision support and LDKT donor
financial assistance to improve their pursuit of LDKT.
Methods
Study design
The Providing Resources to Enhance African American
Patients’ Readiness to Make Decisions about Kidney
Disease (PREPARED) Study was a small, 6-month ran-
domized clinical trial. The intent of PREPARED was to
provide rigorous preliminary evidence that interventions
might be effective to guide the conduct of larger national
trials. We enrolled African American patients with end
stage renal disease who had recently initiated in-center
hemodialysis. We randomly assigned participants with
equal probability to receive [1] usual dialysis care in the
dialysis facility (“Usual Care”), [2] informational decision
aids (i.e., a video and a book describing LDKT and other
forms of renal replacement therapy, referred to as “PRE-
PARED information”), or [3] the PREPARED informa-
tion plus a living kidney donor financial assistance
program (referred to as “PREPARED Plus”). Participants
could not be feasibly blinded to treatment group after re-
ceiving the PREPARED information or financial assistance
interventions. Data collectors assessed outcomes using ob-
jective measures 1, 3, and 6 months after randomization.
The Johns Hopkins School of Medicine Institutional Review
Board approved all protocols and consent procedures. The
Duke University School of Medicine Institutional Review
Board approved all data analysis procedures. The study was
registered with ClinicalTrials.gov [NCT01439516]. Study
enrollment began in April 2012 and concluded in July 2013.
Details of our protocol have been previously published [20].
Study setting and participants
We recruited participants from 11 outpatient hemodialysis
facilities in the Baltimore, MD metropolitan region.
Enrollment initiated in April 2012. Research staff con-
firmed potential participants’ date of dialysis initiation
with dialysis nurses, and they administered questionnaires
in hemodialysis facilities to assess patients’ study eligibility,
including an assessment of their cognitive function (the
MiniCog) [21]. Patients were eligible to participate if they
initiated hemodialysis within 2 years of the date of screen-
ing, spoke English, were age 18 years or older, and had
self-reported African American race. We excluded pa-
tients with self or hemodialysis nurse-reported dementia,
objective cognitive impairment, prior kidney transplant, or
potential medical exclusions from receiving LDKT, includ-
ing cancer within the previous 2 years, advanced congest-
ive heart failure, end stage liver disease, unstable coronary
artery disease, pulmonary hypertension, severe peripheral
vascular disease, or chronic debilitating infections.
Enrollment and randomization
Research staff obtained participants’ informed written
consent and administered participants a pre-enrollment
questionnaire in hemodialysis facilities. Staff then con-
tacted participants via telephone to complete additional
pre-enrollment questions and to conduct trial enroll-
ment and randomization after all eligibility criteria were
met. A statistician not involved in participant recruit-
ment generated the sequence of blocked intervention as-
signments using SAS version 9.3, with equal allocation
to the 3 study arms within randomly selected block sizes
of 3 and 6, stratified by the hemodialysis facilities.
Allocation was concealed to research staff enrolling
participants until the end of the baseline telephone
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interview, when participants were formally enrolled. We
employed the methods of ‘sequentially numbered opaque
sealed envelopes’ for randomization.
Study interventions
The 45-min PREPARED DVD video described LDKT
and other kidney replacement treatment options from
the perspectives of patients receiving each treatment and
their family members. The PREPARED book was written
at a 4th grade reading level and summarized scientific
evidence, derived from systematic literature reviews,
about differences in treatments’ effects on numerous as-
pects of patients’ lives, including longevity, morbidity,
quality of life and financial matters. The development
and content PREPARED decision aids have been de-
scribed elsewhere [20, 22].
The living donor financial assistance program offered
participants’ potential live donors reimbursement up to
$1600.00 for qualifying medical and non-medical ex-
penses related to live kidney donor evaluation, donation,
or post-donation convalescence (up to 10 weeks post live
kidney donor procedures). The program covered a
broader array of expenses related to live kidney donation
than the National Live Donor Assistance Program [23]
and did not require potential donors to qualify based on
their personal incomes [19, 20].
Intervention delivery
Research staff met with participants assigned to receive
study interventions at hemodialysis facilities on non-
hemodialysis days. Staff oriented participants to the con-
tents of the PREPARED book and video using a script
and sat with participants while participants watched the
video. Staff encouraged participants to share PREPARED
materials with their family members and health care
providers. Staff reviewed with participants the features
of live donor financial assistance program using a script.
Staff referred participants to their health care providers
for answers to questions participants had about clinical
care, treatment options, or other aspects of treatment
decision-making after reviewing PREPARED materials.
Participants assigned to “Usual Care” received their
routine medical care in hemodialysis facilities after en-
rollment. Participants in any of the three groups could
have received educational materials or financial assist-
ance through their usual health care.
Data collection
Participant demographic, clinical characteristics, and
experiences with hemodialysis care at enrollment
At enrollment, we assessed participants’ sociodemo-
graphic characteristics and factors that could affect par-
ticipants’ likelihood of identifying potential living kidney
donors, including family function (Family APGAR index,
which measures five aspects of family function) [24] and
their perceived financial well-being or distress (using the
personal financial well-being scale) [25]. We also
assessed participants’ comorbidity (using the Charlson
Comorbidity Index [26] modified for end stage renal dis-
ease) and their presence of depression (using the vali-
dated PHQ-8 [27]). We asked participants how long
they had received care in their current hemodialysis
treatment facility, and we assessed their satisfaction with
care using questions adapted from the Consumer Assess-
ment of Healthcare Providers and Systems (CAHPS®)
In-Center Hemodialysis Survey [28]. We also asked
participants about their preparation for kidney replace-
ment therapy and/or LDKT, initiation of hemodialysis
with a fistula or graft, and their completion of a kidney
transplant recipient medical evaluation and/or place-
ment on a kidney transplant waiting list. We further
asked participants about their concerns regarding
LDKT, rated on a 10-point scale ranging from 0 (no
concern) to 10 (extremely concerned).
Participant perceived involvement in kidney treatment
decisions at enrollment
We asked participants to report their perceived involve-
ment in treatment decisions with the questions, “In the last
12 months, did either your kidney doctors or dialysis center
staff talk to you as much as you wanted about which treat-
ment is right for you?” and “In the last 12 months, were
you as involved as much as you wanted in choosing the
treatment for kidney disease that is right for you?”
Outcomes
Our primary outcome was participants’ newly self-reported
achievement of behaviors reflecting their consideration
and/or pursuit of LDKT at 1, 3, or 6 months follow up.
Behaviors included patients’: [1] discussion about LDKT
with their family members; [2] discussion about LDKT with
their doctor; [3] initiation of the recipient medical evalu-
ation for LDKT; [4] completion of the recipient evaluation
for LDKT; and [5] identification of a potential live kidney
donor. We assessed these LDKT behaviors and any new be-
haviors via participants’ self report by telephone interviews
at baseline and 1, 3, and 6 months after enrollment. We
also assessed participants’ beliefs about kidney transplant
and their concerns about LDKT.
Intervention fidelity and perceived usefulness
Study staff documented the occurrence of in-person meet-
ings with participants to deliver interventions. In a small
number of instances when participants were not able to
meet with study staff, staff mailed or delivered interven-
tions to participants’ homes. We asked participants their
views on usefulness of PREPARED materials in their treat-
ment decision making. We also asked eligible participants
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whether they shared the donor financial assistance pro-
gram with family members or friends.
Statistical analysis
We quantified changes in participants’ probability of
achieving at least one new LDKT action over 6 months
and differences in changes among study groups. The
main independent variable was the randomly assigned
intervention group. We hypothesized a priori that the
PREPARED information intervention alone (designed to
overcome educational barriers to LDKT) and the PRE-
PARED information paired with the financial assistance
intervention (designed to overcome financial barriers to
LDKT) would be more effective at improving partici-
pants’ pursuit of LDKT compared to Usual Care. A
priori, we estimated a sample size of 210 (70 participants
randomized to each group) would provide over 80%
power to detect a trend of increasing LDKT pursuit
across groups at 6 months [29]. We conducted descrip-
tive cross-sectional analyses (using Fisher’s exact test) to
compare differences in participants’ achievement of
LDKT behaviors at any time point among groups at
baseline and 6 months. We also constructed longitudinal
generalized estimating equations (GEEs) to estimate
group differences in participants’ probabilities of accom-
plishing at least one additional LDKT behavior at 1, 3 or
6 months follow up. Models specified an unstructured
correlation structure for repeated measures and adjusted
for participants’ baseline comorbidity scores, which were
not balanced across study groups at baseline. We also
modeled changes in participants’ self-reported beliefs re-
garding transplant and concerns about LDKT at baseline,
1, 3, and 6 months using longitudinal GEEs. We also
conducted a sensitivity analysis accounting for potential
clustering of findings among participants receiving care
in the same hemodialysis facilities. In this analysis, we fit
a simple generalized linear mixed model with a random
intercept for hemodialysis facility and a random inter-
cept for participant (nested within facility). We per-
formed analyses using R version 3.2.0 (R Foundation for
Statistical Computing (2015), Vienna, Austria).
Results
Participant screening, enrollment, and retention
Between April 2012 and July 2013, we assessed the
eligibility of 329 people, of whom 159 were eligible to
participate and 54 declined to participate. A majority of
potential participants (n = 83) were not eligible because
they were medically unsuitable for transplant based on
the exclusion criteria. Of potentially eligible people, 105
consented and completed a baseline-in-person interview,
and 92 completed the enrollment interview via phone.
These 92 participants were randomly assigned to receive
Usual Care (n = 31), PREPARED information (n = 30), or
PREPARED information plus financial assistance (n = 31).
Overall, 84%, 73%, and 90% of participants who were ori-
ginally enrolled completed the 6-month follow-up in the
usual care, PREPARED, and PREPARED Plus groups, re-
spectively. Recruitment fell short of our a priori goal (total
enrollees 210 planned, 70 participants per group) due to ad-
ministrative funding cuts limiting our capacity to expand
recruitment to additional hemodialysis facilities (Fig. 1).
Participant characteristics at enrollment
All 92 study participants were of self-identified African
American race. Participants were similar with regard to
all sociodemographic characteristics. Most (73%) partici-
pants had at least a high school education and over half
(59%) reported annual household incomes of less than
$20,000 annually. Few (13%) were employed full- or
part-time, nearly one third were married, and nearly half
had at least 1 parent living. Half of participants (50%)
had ≥9th grade health literacy. The majority of partici-
pants (62%) had initiated dialysis and received care at
the hemodialysis unit from which they were recruited
within less than 1 year from the time of study enroll-
ment. Median comorbidity scores were statistically sig-
nificantly greater among participants in the usual care
and PREPARED Plus groups compared to participants in
the PREPARED information group. Few participants re-
ported advance preparation for LDKT. Nearly half (46%)
of all participants reported initiating hemodialysis in the
emergency room and a majority (67%) reported initiating
hemodialysis with catheter. Few (18%) reported they had
completed a kidney transplant recipient evaluation, and
a majority reported they were not on a waiting list for a
deceased donor kidney. Participants’ median ratings for
satisfaction with hemodialysis center staff and facilities
were high (Table 1).
Participant perceived involvement in kidney treatment
decisions at enrollment
Nearly one third of all participants reported they had
not talked with any of the doctors, nurses or staff at the
hemodialysis facility about kidney transplant. Similarly,
nearly one third felt they had not talked to kidney doc-
tors or other treatment staff as much as they wanted
about what treatment was right for them over the prior
12 months, and nearly one third reported they were not
as involved as they wanted in choosing the treatment for
kidney disease that was right for them over the prior
12 months. Perceptions were similar among the three
intervention assignment groups.
Effect of PREPARED interventions on LDKT pursuit, beliefs
and concerns
At enrollment, 27% of all participants reported they had
no previous discussions about LDKT with either their
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doctor or with their family or friends, while 7% had both
completed a LDKT evaluation and identified a donor.
After six months follow up, 20% of all participants re-
ported they had had no discussions about LDKT with ei-
ther their doctor or with family or friends, and 16% had
completed an LDKT evaluation and identified a donor.
The proportion of participants achieving LDKT behav-
iors was similar across the study groups (Table 2).
Within each study group, individual participants experi-
enced no statistically significant change in achieved
LDKT behaviors over 6 months, and there was no statis-
tically significant difference in participants’ achievement
of LDKT behaviors across study groups (odds ratio [95%
confidence interval] for individual achievement of 1 add-
itional LDKT behavior within Usual Care, PREPARED,
and PREPARED Plus groups was 1.53 [0.17–13.45], 0.15
[0.0–5.22], and 1.00 [0.22–4.68], respectively, p = 0.66
for differences across groups) (Fig. 2). Findings were
similar in analyses accounting for potential clustering of
participants within their hemodialysis facilities.
Fig. 1 CONSORT Flow Diagram for study eligibility, screening, consent, enrollment, randomization, and follow-up. *Reasons for ineligibility included
deceased at time of contact (n = 6), previous kidney transplant (n = 14), in nursing home or hospice (n = 8), medically unstable (n = 22), Non-African
American (n = 18), receiving hemodialysis for longer than the 1–2 year (n = 1), no longer on hemodialysis or recovered their kidney function (n = 4),
need for proxy (N = 3), switched dialysis treatment center at the time of contact (n = 9), and other (n = 2). **BL = Baseline
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Age [mean, standard deviation] 53 [14] 52[12] 53[16] 55[13] 0.6
Gender 0.3
Female 47 (51) 13 (42) 15 (50) 19 (61)
Male 45 (49) 18 (58) 15 (50) 12 (39)
Highest Level of Education 0.5
High school 67 (73) 21 (68) 23 (77) 23 (74)
2 years of college 12 (13) 6 (19) 2 (7) 4 (13)
College graduate 8 (9) 4 (13) 2 (7) 2 (7)
Graduate/professional school 5 (5) 0 (0) 3 (10) 2 (7)
Annual Household Income 0.2
≤ $10,000 30 (33) 12 (39) 9 (30) 9 (29)
> $10,000 to $20,000 24 (26) 8 (26) 10 (33) 6 (19)
> $20,000 to $40,000 19 (21) 5 (16) 8 (27) 6 (19)
> $40,000 9 (10) 1 (3) 1 (3) 7 (23)
Refused/don’t know 10 (11) 5 (16) 2 (7) 3 (10)
Employment 0.5
Full- or part-time 12 (13) 2 (6) 6 (20) 4 (13)
Student/homemaker 3 (3) 1 (3) 1 (3) 1 (3)
Retired 18 (20) 5 (16) 7 (23) 6 (19)
Retired/disabled 36 (39) 17 (55) 7 (23) 12 (39)
Other/unemployed 23 (25) 6 (20) 9 (30) 8 (25.81)
Marital status 0.1
Married 30 (33) 7 (23) 10 (33) 13 (42)
Separated 3 (3) 1 (3) 2 (7) 0 (0)
Divorced 15 (16) 8 (26) 1 (3) 6 (19)
Single/never married 36 (39) 14 (45) 12 (40) 10 (32)
Widowed 7 (8) 1 (3) 4 (13) 2 (6)
Refused 1 (1) 0 (0) 1 (3) 0 (0)
Family composition
No. of children, median [interquartile range, IQR] 2 [1–4] 2 [2–4] 2 [0–3] 2 [2–4] 0.1
No. of siblings, median [IQR] 3 [1–4] 3 [2–5] 3 [1–4] 3 [2–4] 0.6
At least 1 parent living 45 (49) 13 (42) 17 (57) 15 (48) 0.6
Health insurance
Private 24 (26) 6 (19) 7 (23) 11 (36) 0.4
Medicare 44 (48) 16 (52) 16 (53) 12 (39) 0.5
Medicaid 41 (45) 16 (52) 12 (40) 13 (42) 0.7
Other/uninsured 11 (12) 3 (10) 5 (17) 3 (10) 0.7
Health literacy 0.1
4th–6th grade 9 (10) 4 (13) 0 (0) 5 (16)
7th–8th grade 27 (29) 6 (19) 13 (43) 8 (26)
≥ 9th grade 46 (50) 15 (48) 15 (50) 16 (52)
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Poor vision, could not complete 8 (9) 5 (16) 1 (3) 2 (6)
Refused 2 (2) 1 (3) 1 (3) 0 (0)
Financial well-being or distress, median [IQR] (n = 91)a 5 [4–6] 5 [4–6] 5 [4–6] 6 [4–6]
Clinical comorbidity
Days on hemodialysis, median [IQR] 236 [124–538] 305 [166–520] 198 [87–529] 241 [118–502] 0.5
Comorbidity score, median [IQR]b 2 [0–3] 2 [0–4] 1 [0–2] 2 [0–4] 0.04
Comorbidity score tertile 0.03
Lowest, 0 points 30 (33) 8 (26) 11 (37) 11 (35)
Middle, 1–2 points 32 (35) 9 (29) 15 (50) 8 (26)
Highest, 3–8 points 28 (30) 13 (42) 3 (10) 12 (39)
Missing 2 (2) 1 (3) 1 (3) 0 (0)
Met definition of depression 0.2
No, PHQ-8 score < 10 23 (25) 4 (12.9) 9 (30) 10 (32.26)
Yes, PHQ-8 score≥ 10 68 (74) 26 (84) 21 (70) 21 (68)
Missing 1 (1) 1 (3) 0 (0) 0 (0)
Depression score, mean (SD) 6(5) 5(3) 6(5) 6(5) 0.9
Dialysis Center Experience
Time Receiving Care in Dialysis Center 0.9
Less than 3 months 17 (19) 4 (13) 7 (23) 6 (19)
At least 3 months but less than 1 year 39 (43) 14 (47) 11 (37) 14 (45)
12 to 18 months 15 (16) 6 (20) 5 (17) 4 (13)
18 months to 2 years 7 (8) 2 (7) 2 (7) 3 (10)
Missing 2 (2) 0 (0) 1 (3) 1 (3)
Dialysis Center Satisfaction Ratingsc
Rating of dialysis center staffc 9 [8–10] 10 [8–10] 9 [8–10] 8 [7–10] 0.4
Rating of dialysis facilityc 9 [8–10] 10 [8–10] 9 [8–10] 8 [7–10] 0.3
Advance Preparation for LDKT
Dialysis initiation 0.9
Planned/dialysis facility 16 (17) 5 (16) 5 (17) 6 (19)
Planned/hospital 35 (38) 13 (42) 11 (37) 11 (35)
Urgent/emergency room 41 (46) 13 (42) 14 (47) 14 (45)
Dialysis initiation with catheter 0.4
No 28 (30) 6 (19) 11 (37) 11 (35)
Yes 62 (67) 24 (77) 19 (63) 19 (61)
Don’t know 2 (2.17) 1 (3.23) 0 (0) 1 (3)
Completed KT evaluation 17 (18) 7 (23) 4 (13) 6 (19)
Waitlisted for KT 0.6
No 69 (75) 23 (74) 20 (67) 26 (84)
Yes 16 (17) 5 (16) 7 (23) 4 (13)
Don’t know 7 (8) 3 (10) 3 (10) 1 (3)
anumbers are n(%) unless otherwise specified; p values for comparisons across study groups at baseline bSelf-report Charlson comorbidity index weighted for end
stage renal disease, scored from 0 to 43 with higher scores indicating greater comorbidity; cTotal Score possible 10, with higher scores indicating greater satisfaction
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At enrollment, the majority of all participants reported
they felt transplant would help them feel better on a day-
to-day basis (n = 51, 55%), help them live longer (n = 60,
65%), and cost more out of pocket (n = 48, 52%) compared
to hemodialysis. Fewer than half (n = 40, 44%) reported they
felt transplant would require more help from their family
with taking them to appointments and assisting with daily
activities. Participants’ beliefs did not statistically signifi-
cantly change over 6 months follow up and were not
statistically significantly different among study groups in
GEE models (Fig. 3). At enrollment, participants overall
were most concerned about their family members’ safety
after the surgery, their own safety during transplant surgery,
feeling guilty or indebted to their family member, and fam-
ily members’ money matters after LDKT donation. Partici-
pants’ beliefs did not statistically significantly change over
6 months follow up and were not statistically significantly
different among study groups in GEE models (Table 3).
Table 2 Accomplishment of behaviors reflecting pursuit of LDKT at baseline and 6 months after interventions


















Behavior Accomplished 0.30 0.9
No behaviors 25 (27) 8 (26) 9 (30) 8 (26) 15 (20) 4 (15) 5 (23) 6 (23)
Discussed with doctor or
family (not both)
20 (22) 4 (13) 5 (17) 11 (36) 17 (23) 6 (23) 5 (23) 6 (23)
Discussed with doctor and family 21 (23) 10 (33) 8 (27) 3 (10) 16 (22) 5 (19) 6 (27) 5 (19)
Started evaluation, no donor
identified
3 (3) 1 (3) 0 (0) 2 (7) 3 (4) 1 (4) 0 (0) 2 (8)
Completed evaluation, no donor
identified
3 (3) 0 (0) 1 (3) 2 (7) 1 (1) 1 (4) 0 (0) 0 (0)
Started evaluation, donor
identified
14 (14) 6 (19) 4 (13) 4 (13) 10 (14) 5 (19) 2 (9) 3 (12)
Completed evaluation, donor
identified
6 (7) 2 (7) 3 (10) 1 (3) 12 (16) 4 (15) 4 (18) 4 (15)
*p values for comparisons across study groups at baseline and across study groups at 6 months
a b
Fig. 2 Unadjusted observed proportion (Panel a) and adjusted (for participants’ baseline comorbidity scores) predicted probability (Panel b) of
participants achieving 1 additional live donor kidney transplantation behaviors at 1, 3 and 6 months. In longitudinal GEE analyses, the Odds Ratio
(95% CI) for an individual participant achieving at least 1 new behavior over 6 months was 1.53 (0.17, 13.45), 0.15 (0, 5.22), and 1.0 (0.22, 4.68), for
participants in the usual care, PREPARED, and PREPARED Plus groups, respectively (p = 0.66 in test for global differences across groups in the
adjusted analysis)
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Intervention fidelity and perceived usefulness
Most participants enrolled in the PREPARED (n = 29,
97%) or PREPARED Plus (n = 31, 100%) groups met
with study staff to receive the interventions. A ma-
jority of participants reported the PREPARED video
and book were helpful with numerous aspects of in-
formed decision-making (Table 4). Fewer than one
third of PREPARED Plus participants reported shar-
ing the financial intervention with a potential donor
at 1 (n = 6, 27%), 3 (n = 8, 30%), or 6 (n = 6, 24%)
months after enrollment. None of the participants
enrolled in PREPARED Plus arm utilized the living
donor financial assistance program.
Discussion
In this small clinical trial, we found that providing infor-
mational decision aids and offering donor financial as-
sistance to African Americans receiving in-center
hemodialysis did not appear to increase their pursuit of
LDKT over 6 months, despite participants’ desires to be
more involved in their LDKT decisions and their posi-
tive beliefs about LDKT. Interventions also had no effect
a b
c d
Fig. 3 Proportion of participants stating they thought a transplant would help them feel better on a day-to-day basis (panel a), help them live
longer (panel b), cost more money out of pocket than other treatments (panel c), or require more day-to-day help from family (panel d) at
baseline, 1, 3, and 6 months follow up. In generalized estimating equation models, individuals’ beliefs did not statistically significantly change
during the study and there were no statistically significant differences between study groups
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on participants’ views of the potential benefits of LDKT
or their concerns about LDKT. Participants found infor-
mational decision aids helpful in thinking about and
making decisions about their treatment choices, but they
were no more likely to initiate LDKT discussions with
their families or doctors or to complete other key LDKT
behaviors (e.g., transplant evaluation). Further, partici-
pants who were offered the donor financial assistance
program did not utilize it. These findings provide im-
portant preliminary evidence regarding the deployment
of these interventions in clinical settings as well as con-
siderations for their study in future large scale studies.
To our knowledge, this is the first rigorously con-
ducted trial to study the effect of providing informa-
tional decision aids or offering donor financial assistance
on potential African American recipients’ pursuit of
LDKT. A previous observational study suggested educa-
tion could increase patients’ readiness to pursue LDKT,
especially among women and other subgroups, but this
study did not employ a comparison group or explore ef-
fects of education longitudinally [30]. Another observa-
tional study demonstrated that African Americans
presenting to a transplant center with higher levels of
transplant knowledge were more likely to receive LDKT
Table 3 Participants’ median [interquartile range] ratingsa of potential concerns regarding LDKT at baseline and follow-up
















Need for help after surgery 5 [0–8] 5 [0–8] 4 [0–7] 5 [0–9] 0.54 5 [0–8] 4 [0–8] 5 [0–10] 1 [0–5] 0.15
Future ability to have children 0 [0–8] 0 [0–7] 0 [0–8] 0 [0–6] 0.9 0 [0–4] 0 [0–1] 0 [0–5] 0 [0–0] 0.74
Recipients’ money matters 5 [0–10] 7 [4–10] 5 [0–10] 5 [0–10] 0.2 2 [0–9] 0 [0–7] 5 [0–9] 0 [0–8] 0.51
Family members’ money matters 6 [0–10] 10 [5–10] 5 [0–7] 6 [2–10] < 0.01 4 [0–10] 5 [0–10] 5 [0–10] 0 [0–7] 0.23
Recipient safety during surgery 8 [5–10] 8 [5–10] 8 [5–10] 8 [5–10] 0.74 6 [0–10] 7 [1–10] 6 [0–9] 6 [0–10] 0.66
Family members’ safety during
surgery
10 [6–10] 10 [8–10] 8 [5–10] 10 [6–10] 0.45 8 [5–10] 7 [4–10] 10 [6–10] 8 [3–10] 0.59
Family member feeling pressured
or guilty
5 [0–10] 8 [0–10] 5 [0–10] 5 [0–9] 0.57 2 [0–9] 5 [0–9] 4 [0–10] 0 [0–5] 0.41
Recipient feeling guilty or indebted 7 [0–10] 6 [0–10] 6 [1–10] 8 [0–10] 0.85 2 [0–10] 6 [0–10] 5 [0–10] 0 [0–5] 0.08
Concern about relationship with
family member donor
3 [0–8] 5 [0–10] 1 [0–6] 3 [0–8] 0.52 0 [0–7] 1 [0–9] 0 [0–5] 0 [0–4] 0.27
aParticipants rated their concerns from 0 (no concern) to 10 (extremely concerned); In GEE analyses. Individuals’ concerns about LDKT did not statistically significantly
change during study follow-up, and there were no statistically significant differences in concerns among study groups
Table 4 Participants’ views on helpfulness of informational materials regarding treatment decision-making 1 month, 3 months, and
6 months after enrollment



















PREPARED video and book helpeda participants to:
Think about treatment choices 16 (73) 11 (52) 16 (67) 21 (78) 16 (73) 13 (52)
Prepare to make a better decision about future
kidney disease treatments
16 (73) 13 (62) 12 (50) 19 (70) 14 (64) 14 (56)
Think about the pros and cons of different treatment
options in the future
16 (73) 13 (62) 17 (71) 18 (67) 15 (68) 14 (56)
Think about which pros and cons are most important 15 (68) 14 (67) 15 (63) 18 (67) 15 (68) 14 (61)
Know that the choice depends on what matters most
to them
17 (77) 13 (62) 15 (63) 19 (70) 16 (73) 17 (68)
Organize their thoughts about the choice 14 (64) 14 (67) 13 (54) 19 (70) 14 (64) 14 (56)
Think about how involved they want to be in the decision 16 (73) 14 (67) 16 (67) 20 (74) 17 (77) 17 (68)
Identify questions to ask their doctor 13 (59) 13 (62) 15 (63) 18 (67) 16 (73) 15 (60)
Prepare to talk to their doctor about what matters most
to them
13 (59) 14 (67) 16 (67) 18 (67) 16 (73) 15 (60)
aProportion of participants saying the PREPARED video and book helped them “quite a bit” or “a great deal” with decision making aspects listed (versus “somewhat,”
“a little,” or “not at all”
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within 1 year [31]. However this study also did not ran-
domly assign educational interventions and could have
been subject to residual confounding, particularly if
those with greater transplant knowledge had other types
of resources available to them that were not accounted
for in the study design. We are aware of no prior study
of the effectiveness of a living donor financial support
intervention to improve pursuit of LDKT among African
American hemodialysis patients.
Consistent with other studies, we found that many African
American patients reported they started hemodialysis
urgently or emergently [32–35], had not completed a
transplant evaluation within 1–2 years of initiating in-
center hemodialysis, and nearly one third could not
recall speaking to medical staff about the kidney
transplant process [36, 37]. The practice of providing
educational materials to patients about kidney transplant
is widespread and advocated as a key mechanism to guide
patients toward transplant [18]. However, it is unclear
when patients most commonly receive education in rela-
tion to dialysis initiation. Although dialysis facilities are re-
quired to discuss transplantation as a treatment option,
the extent to which patients initiating hemodialysis actu-
ally receive or appreciate these discussions has been
poorly studied. It is also unclear whether patients who
have established long term relationships prior to dialysis
are more likely to receive information from nephrologists
and to be motivated to seek transplant. Since many study
participants reported they initiated dialysis urgently, it is
possible they had limited opportunities to discuss LDKT.
Our study did not explore whether circumstances sur-
rounding patients’ dialysis initiation or patients’ relation-
ships with their nephrologists could influence their
willingness to seek LDKT. We also did not explore rea-
sons why patients had not discussed LDKT with their
physicians. Studies exploring these potential influences on
patients’ willingness to seek transplant are warranted.
Our findings ran contrary to our a priori hypotheses.
Although a majority of participants reported they de-
sired more engagement in treatment decisions and
found PREPARED informational materials helpful, it is
possible potential LDKT recipients may require different
or adjunctive support beyond self-directed education to
act on LDKT decisions. Other studies suggest that the
effect of decision aids on changing patients’ actual health
behaviors may be weak, particularly if health care
providers do not assist with decision making or patient
activation [38, 39]. Previous trial findings suggest inter-
ventions in which transplant teams or lay people directly
engage potential transplant recipients to help them con-
sider LDKT, reach out to potential donors [40–42], and
navigate patients [43] to complete transplant evaluations
are effective in helping patients pursue and obtain
LDKT. Further, PREPARED interventions did not provide
support for certain LDKT behaviors we measured, includ-
ing support for talking to their family members or
transplant professionals about LDKT. A prior trial demon-
strated that interventions (including educational materials
and social worker support) providing patients support to
talk about LDKT with family members and health care
professionals improved these behaviors [42]. Many of our
participants were unemployed or disabled, and they may
have benefitted from assistance to complete complex pro-
cesses related to LDKT. Potential LDKT recipients may
also have needed more direct assistance to take advantage
of the LDKT financial assistance program (e.g., via more
intensive financial counseling). In our own prior qualita-
tive studies, potential LDKT recipients reported feeling
awkward discussing the potential financial risks of LDKT
with potential donors and they cited the value of profes-
sional assistance from others (e.g., social workers) to aid
with this aspect of the LDKT process [15, 44].
It is worth noting that PREPARED informational deci-
sion aids were intended to promote patients’ informed
decisions to choose renal replacement therapies that are
aligned with their personal values, a goal that is defined
as essential to patient centered care [45, 46]. Thus
PREPARED materials did not explicitly encourage LDKT
as a preferred treatment choice, but instead presented
the benefits and risks LDKT in the context of the bene-
fits and risks of other potential treatment options (in-
cluding dialysis and conservative management) [22]. It is
possible that study participants not seeking LDKT in
our study made values-based decisions to remain on in-
center hemodialysis. Prior studies have shown patients
newly initiating in-center hemodialysis often undergo
significant physical and psychological adjustments that
could interfere with their capacity to make major behav-
ioral changes [47]. It is also important to note that
PREPARED did not focus specifically on potential LDKT
donors’ outcomes or safety of the LDKT procedure.
Since many participants expressed concerns about the
impact of LDKT on safety and on donors, information
may not have addressed key concerns which could hin-
der participants’ willingness to pursue LDKT. Notably, a
majority of study participants had adequate (i.e., >9th
grade) health literacy, suggesting that health literacy was
not a barrier to participants’ interpretation of informa-
tional materials.
Limitations of our study include its conduct among a
small number of African Americans in a single geographic
region. Since we did not meet our planned recruitment
goal, it is possible our study was underpowered to detect
smaller effects of our interventions on pursuit of LDKT. A
small proportion of our participants had already com-
pleted LDKT evaluations or identified a donor at baseline,
which may have further limited our capacity to detect im-
provements in LDKT pursuit among the study population.
Boulware et al. BMC Nephrology  (2018) 19:107 Page 11 of 14
Further, only a small subset of participants who were in-
terested in LDKT at baseline would have been eligible to
pursue the financial assistance intervention, limiting our
capacity to assess this intervention. We only followed par-
ticipants for 6 months. It is possible patients require sub-
stantial time to accomplish LDKT behaviors, particularly
when have recently initiated in-center hemodialysis, and
are likely to experience substantial physical and psy-
chological adjustment to their treatment [48–51]. For
patients who are just initiating dialysis and may have
limited exposure to transplantation, longer follow up
(e.g., up to 10 years) may be needed to assess the
long term impact of PREPARED interventions. We
also did not measure changes in general transplant-
decision-making or transplant knowledge as primary
outcomes, which could also be important indicators
of willingness to seek LDKT. Importantly, we also did
not collect information on the education provided to
participants in the course of their usual care. While
all three intervention groups would have received this
information, it is possible that PREPARED informa-
tion was not viewed as complimentary to usual edu-
cation or that usual education varied across dialysis
centers. Behaviors toward LDKT have not been vali-
dated as a strong predictor of receiving LDKT. Mea-
sures to validate behaviors toward LDKT should be
developed and could be deployed in future studies.
Finally, it is possible participants who received the
intervention could have shared the video and the
book with others in the dialysis facility, contaminating
our findings. However, we advised participants not to
share the interventions with others and participants
in the usual care group reported they had not seen
the video or the book. Finally, although we believe
patients received standard of care, it is possible par-
ticipants’ behaviors were influenced by practice pat-
terns (e.g., transplant referrals processes) within their
dialysis facilities. Despite these limitations, this study
is among the first to quantify the impact of broadly
supported interventions to improve LDKT and pro-
vides important insight to guide future interventions.
Larger studies with longer observation periods may
be needed to more accurately assess the value of
these interventions to address LDKT disparities.
Conclusions
In summary, informational decision aids and living
donor financial support interventions were viewed favor-
ably by African American potential LDKT recipients but
did not improve their pursuit of LDKT in a small pre-
liminary trial. Larger studies designed with longer follow
up and deploying these interventions in ways that might
better facilitate their uptake to improve African Americans’
receipt of LDKTare urgently needed.
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